Natural killer cell dysfunction is associated with colorectal cancer with severe COVID-19

doi:10.4251/wjgo.v17.i5.104591

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (913)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

HTML

302

Figures (1-5)

111

Tables (1-3)

115

Sum=549

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

183

Sum=281

Publishing Process of This Article

Item

Count

Browse

Download

Sum=58

May 15, 2025 (publication date) through Jun 12, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. May 15, 2025; 17(5): 104591
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.104591

Table 1 Characteristic features of study populations

	CRC patients	CRC⁺ patients
Number	15	15
Age	61.9 (43-75)	60.0 (43-73)
Gender (male:female)	8:7	8:7
BMI (kg/m²)	25.93 ± 3.48	25.95 ± 3.38
TNM stage
I	10	9
II	5	6
Degree of differentiation
High	1	1
Moderately	14	14

CRC: Colorectal cancer; CRC⁺: Colorectal cancer with severe coronavirus disease 2019; BMI: Body mass index; TNM: Tumor-node-metastasis.

Citation: Wang JF, Zhang LZ, Liu T, Meng QH, Mu JW, Wang YL. Natural killer cell dysfunction is associated with colorectal cancer with severe COVID-19. World J Gastrointest Oncol 2025; 17(5): 104591
URL: https://www.wjgnet.com/1948-5204/full/v17/i5/104591.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i5.104591